IBCL-489 Mosunetuzumab Retreatment Is Effective and Well-Tolerated in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
Clinical Lymphoma, Myeloma & Leukemia（2023）
关键词
IBCL,mosunetuzumab,relapsed lymphoma,follicular lymphoma,diffuse large B-cell lymphoma,non-Hodgkin lymphoma,phase I/II
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要